[go: up one dir, main page]

ES8202784A1 - Secondary amines, their preparation and use in pharmaceutical compositions. - Google Patents

Secondary amines, their preparation and use in pharmaceutical compositions.

Info

Publication number
ES8202784A1
ES8202784A1 ES496267A ES496267A ES8202784A1 ES 8202784 A1 ES8202784 A1 ES 8202784A1 ES 496267 A ES496267 A ES 496267A ES 496267 A ES496267 A ES 496267A ES 8202784 A1 ES8202784 A1 ES 8202784A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
secondary amines
methyl
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES496267A
Other languages
Spanish (es)
Other versions
ES496267A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8202784A1 publication Critical patent/ES8202784A1/en
Publication of ES496267A0 publication Critical patent/ES496267A0/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Compounds of formula (III): < IMAGE > (III) and esters, amides and pharmaceutically acceptable salts thereof, wherein A1 is hydrogen or methyl A2 is hydrogen or methyl and n is 1, 2 or 3 have anti-obesity activity. Methods for their preparation pharmaceutical formulations of the compounds and their use in medicine are described.
ES496267A 1979-10-25 1980-10-24 A PROCEDURE FOR THE PREPARATION OF SECONDARY AMINE DERIVATIVES. Granted ES496267A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7937084 1979-10-25

Publications (2)

Publication Number Publication Date
ES8202784A1 true ES8202784A1 (en) 1982-02-16
ES496267A0 ES496267A0 (en) 1982-02-16

Family

ID=10508767

Family Applications (2)

Application Number Title Priority Date Filing Date
ES496267A Granted ES496267A0 (en) 1979-10-25 1980-10-24 A PROCEDURE FOR THE PREPARATION OF SECONDARY AMINE DERIVATIVES.
ES507414A Expired ES8207124A1 (en) 1979-10-25 1981-11-24 Secondary amines, their preparation and use in pharmaceutical compositions.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES507414A Expired ES8207124A1 (en) 1979-10-25 1981-11-24 Secondary amines, their preparation and use in pharmaceutical compositions.

Country Status (11)

Country Link
US (1) US4329358A (en)
EP (1) EP0028105B1 (en)
JP (1) JPS5681546A (en)
AT (1) ATE2265T1 (en)
CA (1) CA1159467A (en)
DE (1) DE3061693D1 (en)
DK (1) DK452980A (en)
ES (2) ES496267A0 (en)
IL (1) IL61333A0 (en)
NZ (1) NZ195340A (en)
ZA (1) ZA806519B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
US4845127A (en) * 1978-07-03 1989-07-04 Eli Lilly And Company Phenethanolamines, compositions containing the same and method for effecting weight control
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
DE3462789D1 (en) * 1983-08-17 1987-04-30 Beecham Group Plc 2-phenylethylamine derivatives
DE3466387D1 (en) * 1983-11-04 1987-10-29 Beecham Group Plc Tertiary amines
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
JPH03154305A (en) * 1989-11-13 1991-07-02 Jgc Corp Manufacture of superconducting coil
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368197B (en) * 1968-11-18 1974-06-24 Pfizer
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
GB1413911A (en) * 1973-08-18 1975-11-12 Pfizer Ltd Preparation of propanolamine derivatives
GB1593651A (en) * 1977-02-03 1981-07-22 Allen & Hanburys Ltd Amides
DK31578A (en) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd PROCEDURE FOR THE PRODUCTION OF BENZENE DERIVATIVES
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
DK160936C (en) * 1978-07-03 1991-10-21 Lilly Co Eli METHOD OF ANALOGUE FOR THE PREPARATION OF OPTICALLY ACTIVE PHENETHANOLAMINES

Also Published As

Publication number Publication date
ZA806519B (en) 1981-10-28
US4329358A (en) 1982-05-11
CA1159467A (en) 1983-12-27
DK452980A (en) 1981-04-26
IL61333A0 (en) 1980-12-31
EP0028105B1 (en) 1983-01-19
NZ195340A (en) 1984-11-09
JPS5681546A (en) 1981-07-03
DE3061693D1 (en) 1983-02-24
ES507414A0 (en) 1982-09-01
EP0028105A1 (en) 1981-05-06
ATE2265T1 (en) 1983-02-15
ES496267A0 (en) 1982-02-16
ES8207124A1 (en) 1982-09-01

Similar Documents

Publication Publication Date Title
ES8207124A1 (en) Secondary amines, their preparation and use in pharmaceutical compositions.
ES8202799A1 (en) Sulfonyl ureas, processes for their preparation and pharmaceutical compositions containing these compounds.
ES463877A1 (en) Analgesic n-(2-aminocycloaliphatic)benzamides
ES8101068A1 (en) Amino-pyrimidine-carbanilides, process for their preparation, medicines containing them.
DE3065304D1 (en) Morpholine derivatives, pharmaceutical compositions containing them and processes for their preparation
ES8307210A1 (en) Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them.
ES8401961A1 (en) Substituted N-(4-indolyl-piperidino-alkyl) benzimidazolones, processes for their preparation and their use as pharmaceutical preparations.
JPS5246060A (en) Delta 155steroid * preparation thereof and pharmaceutical agent containing the same
IL61496A0 (en) Secondary amines,their preparation and pharmaceutical compositions containing them
ES8404852A1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use.
IL59603A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
SE8004383L (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION AND PROCEDURE FOR ITS PREPARATION
ES487631A1 (en) Hexahydro-1,4-oxazepines, process for their preparation and pharmaceutical compositions containing them.
ES448645A1 (en) Substituted cyclopropyl benzamides and pharmaceutical preparations and methods of use employing such compounds
ES445969A1 (en) Substituted piperazine derivative, its preparation and anorexia compositions containing it
IE43848L (en) Pharmaceutical compositions